Browsing by 키워드 : PD-L1
전체 결과 17건 중 1-17 번을 표시중입니다.
- 1 Article A frst-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors Stephen L Chan ; Martin Schuler ; Yoon-Koo Kang ; et al 2022
- 2 Article Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial 이대호 ; Byoung Chul Cho ; Chia-Chi Lin ; et al 2020
- 3 Article Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer 공경엽 ; 김덕훈 ; 김상위 ; et al 2020
- 4 Article Epstein-Barr virus encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas 윤찬진 ; 장미수 ; 김동하 ; et al 2020
- 5 Article Identification of New Prognostic Markers and Therapeutic Targets for Non-Muscle Invasive Bladder Cancer: HER2 as a Potential Target Antigen Han Kyu Chae ; Wook Nam ; Han Gwun Kim ; et al 2022
- 6 Article Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate Ji Min Kim ; Binnari Kim ; Eunji Kim ; et al 2022
- 7 Article LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation Eunsil Sung ; Minkyung Ko ; Ju-Young Won ; et al 2022
- 8 Article PD-L1 expression in paired biopsies and surgical specimens in gastric adenocarcinoma: A digital image analysis study 허유정 ; 김빛나리 ; 김현진 ; et al 2021
- 9 Article PD-L1 expression in paired biopsies and surgical specimens in gastric adenocarcinoma: A digital image analysis study 허유정 ; 김빛나리 ; 김현진 ; et al 2021
- 10 Article Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma Guru P Sonpavde ; Cora N Sternberg ; Yohann Loriot ; et al 2022
- 11 Article Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05. 김상위 ; 민영주 ; Byoung-Yong Shim ; et al 2021
- 12 Article Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 홍승모 ; Aldo Scarpa ; Andrea Mafficini ; et al 2021
- 13 Article Two-year efficacy of SNK01 plus pembrolizumab for non-small cell lung cancer: Expanded observations from a phase I/IIa randomized controlled trial Hyung Jun Park ; Yong Man Kim ; Jae Seob Jung ; et al 2022
- 14 Article Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma 이재련 ; A. Chudnovsky ; A. di Pietro ; et al 2020
-
15
Dissertation
다중 면역형광 패널을 이용한 하인두암의 종양 내 침윤 림프구의 분포와 같이 발현되는 면역학적 지표
김예리
2018
-
16
Dissertation
수술적 치료를 받은 간세포암에서 면역관문 조절 인자가 임상경과에 미치는 영향
안지현
2017
-
17
Dissertation
진행성 암에서의 신흥 바이오마커: 예후적 함의와 치료 목표로서의 잠재성
김미정
2024
1